VGK — Vanguard FTSE Europe ETF
Price when we picked it (Mar 9, 2026)
$84.64
P/E Ratio
14.0
P/E Forward
13.2
Dividend
3.7%
Market Cap
$19B
EPS
—
Consensus
N/A (ETF)
What they do
VGK tracks the FTSE Developed Europe All Cap Index. It gives you access to 1,246 companies in 16 European countries: UK (22%), France, Switzerland, Germany, Netherlands, and more. Includes global leaders like ASML, Roche, Nestlé, SAP, and AstraZeneca.
Why we like it
Cheap geographic diversification (0.06% expense ratio). Europe offers generous dividends (3.7%). Attractive pricing at price vs. profit ~14x vs. S&P 500 at ~21x. Natural hedge against a weak dollar.
Key Risk
European economic growth has historically been slower than the US. Currency risk with EUR/GBP/CHF. Lacks American mega-cap tech companies that have led returns.
This is educational and informational content, not financial advice. Always consult a qualified financial advisor before making investment decisions.
Vectorial Data picked VGK on Mar 9, 2026 at $84.64.
Full Research
VGK — Vanguard FTSE Europe ETF — Complete Research
Price: $84.25 | Expense Ratio: 0.06% | Div Yield: 3.7% | AUM: $19B+
What is VGK?
VGK is a Vanguard ETF that tracks the FTSE Developed Europe All Cap Index. It offers diversified exposure to more than 1,246 companies in 16 developed European countries. It's one of the cheapest and most efficient ways to invest in the European market.
Country Composition
| Country | % of ETF |
|---|---|
| United Kingdom | ~22% |
| France | ~16% |
| Switzerland | ~14% |
| Germany | ~13% |
| Netherlands | ~8% |
| Others (11 countries) | ~27% |
Top 10 Holdings
| Company | Ticker | % of ETF |
|---|---|---|
| ASML Holding | ASML | 2.83% |
| Roche | ROG | 1.93% |
| AstraZeneca | AZN | 1.85% |
| Nestlé | NESN | 1.76% |
| Novartis | NOVN | 1.68% |
| SAP | SAP | 1.62% |
| Shell | SHEL | 1.58% |
| HSBC | HSBA | 1.31% |
| Novo Nordisk | NOVO | 1.28% |
| TotalEnergies | TTE | 1.20% |
Sector Distribution
| Sector | % |
|---|---|
| Financials | ~20% |
| Industrials | ~16% |
| Healthcare | ~14% |
| Consumer Discretionary | ~11% |
| Technology | ~9% |
| Others | ~30% |
Why Do We Like It?
- Geographic diversification — 16 countries, 1,246 companies. Reduces concentration risk in the US
- Expense ratio of 0.06% — almost free. You pay $0.60 for every $1,000 invested
- Dividend of 3.7% — more than double that of the S&P 500. Europe pays generous dividends
- Attractive pricing — Europe trades at price vs. profit ~14x vs. S&P 500 at ~21x. 33% discount
- Exposure to global leaders — ASML (monopoly in lithography), Nestlé, Roche, SAP, Novo Nordisk
- Hedge against a weak dollar — if the USD weakens, assets in EUR/GBP/CHF appreciate in USD
Risks
- Slower European economic growth compared to the US historically
- Currency risk — EUR/GBP/CHF may weaken vs. USD
- Exposure to UK post-Brexit — 22% of the fund is in the UK
- Lacks tech mega-caps — doesn't include the American 'Magnificent 7' that have led returns
Research date: Mar 9, 2026 | Next review: Sep 2026
This is not financial advice.
This is not financial advice. Consult a certified financial advisor.
The author may hold positions in the securities discussed.
Past performance does not guarantee future results.